Indocyangreen Elimination in Cirrhosis and Acute Liver Failure
Indocyangreen (ICG)is totally biliary eliminated and corresponds to hepatocyte function and liver perfusion.
The ICG-clearance will be evaluated as a prognostic marker in liver disease.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Evaluation of the Indocyangreen Elimination as a Prognostic Marker in Decompensated Cirrhosis and Acute Liver Failure|
|Study Start Date:||October 2005|
|Study Completion Date:||October 2010|
|Primary Completion Date:||October 2010 (Final data collection date for primary outcome measure)|
patients with acute liver failure or advanced liver disease will be studied. ICG-clearance will be correlated with established clinical scores and outcome.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00245310
|University of Heidelberg|
|Heidelberg, Germany, 69120|
|Principal Investigator:||Jens Encke, PD Dr. med.||Heidelberg University|